Drug Topics

JANUARY 20, 2025

The lawsuit alleges Walgreens has been filling prescriptions in violation of the Controlled Substances Act since 2012.

Prescription Filling 469

Prescription Filling Controlled Substances 469

The Checkup by Singlecare

JANUARY 20, 2025

Losing weight can be tough. And it can be even tougher for people who have Type 2 diabetes, which can impair weight loss. Thats why it might seem natural to treat both obesity and diabetes simultaneously. For the past half-century, phentermine has been one of the most commonly prescribed weight loss drugs, and metformin has been one of the most popular diabetes medicationsand its also prescribed off-label for weight reduction.

Dosage 98

Dosage Labelling Controlled Substances Insurance 98

Drug Topics

JANUARY 20, 2025

Jonathan Watanabe, PharmD, MS, PhD, BCGP, discussed a section of the ASHP 2025 Pharmacy Forecast that he co-authored titled Addressing the Gap in Primary Care.

247

247

Fierce Healthcare

JANUARY 20, 2025

Though it was dismissed from an antitrust lawsuit last year, the threat of a second administrative case pushed the private equity firm toward a settlement. Though the agency and its chair celebrated the deal as a victory over private equity, the firm and the agency's upcoming head suggested political posturing.

122

122

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

The Checkup by Singlecare

JANUARY 20, 2025

Ibuprofen is a type of nonsteroidal anti-inflammatory drug ( NSAID ) that is used to treat various inflammatory conditions. Its available both as an over-the-counter (OTC) drug and by prescription. As an OTC medication, ibuprofen is approved by the Food and Drug Administration (FDA) to treat fever, pain, menstrual cramps, headaches, migraines, sore throats, cold and flu symptoms, joint pain and stiffness, and dental pain.

Dosage 52

Dosage Labelling FDA 52

Pharmacy Times

JANUARY 20, 2025

The authors found that humidity, cold and heat waves, and air pollution led to a higher likelihood of asthma- and chronic obstructive pulmonary disease (COPD)-related hospitalizations.

Hospitals 115

Hospitals 115

Pharmacy Times

JANUARY 20, 2025

The reduction in cardiovascular end points and the increase in adverse events observed in a clinical trial were largely transportable to trial-eligible chronic kidney disease (CKD) populations from clinical practice.

107

107

Fierce Healthcare

JANUARY 20, 2025

U.S. District Judge Matthew Kacsmaryk ruled Thursday that Idaho, Kansas and Missouri may move forward on a challenge to the regulatory clearance of mifepristone.

95

95

Pharmacy Times

JANUARY 20, 2025

The Justice Department alleges that Walgreens acted in violation of the Controlled Substances Act and sought reimbursement for unlawful prescriptions, violating the False Claims Act.

Controlled Substances 101

Controlled Substances 101

Fierce Healthcare

JANUARY 20, 2025

GE Healthcare struck a seven-year agreement with Sacramento, California-based Sutter Health to provide AI-powered medical imaging technology and digital solutions. The health system's work with GE Healthcare also supports Sutters larger access strategy, as the nonprofit system aims to expand its ambulatory footprint.

82

82

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

JANUARY 20, 2025

Experts presented results that may transform treatment and clinical practice strategies.

101

101

Outsourcing Pharma

JANUARY 20, 2025

We ran a Q&A With Michael Young, co-founder of Lindus Health on the challenges of 2024 and the companys goals for 2025.

74

74

Pharmacy Times

JANUARY 20, 2025

Increased technician involvement also improves patient care nationwide.

Patient Care 95

Patient Care 95

Pharmaceutical Commerce

JANUARY 20, 2025

In the third part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Donald Prentiss, founder and CEO, Qualthera, explains how collaboration between compounding pharmacies, drug manufacturers, and telehealth platforms can drive success, despite the various litigations pertaining to GLP-1s that currently taking place.

Compounding Pharmacies 64

Compounding Pharmacies Compounding 64

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

JANUARY 20, 2025

Panelists discuss how untreated tardive dyskinesia severely impacts patients' daily functioning and quality of life through physical limitations affecting basic tasks like eating and walking, social isolation due to visible symptoms, and heightened risks for older adults who face increased fall risks, difficulty maintaining independence, and complications from age-related comorbidities.

65

65

Pharmaceutical Technology

JANUARY 20, 2025

AstraZeneca has received approval from the FDA for its BTK inhibitor, Calquence (acalabrutinib), for first-line use in MCL.

FDA 64

FDA 64

Fierce Healthcare

JANUARY 20, 2025

Welcome to this week's Chutes & Ladders, our roundup of hirings, firings and retirings throughout the industry. Please submit the good newsor the badfrom your shop, and we will feature it here at the end of each week.

59

59

Pharmaceutical Technology

JANUARY 20, 2025

This week, at the J.P. Morgan Healthcare Conference and the Biotech Showcase, discussions underscored the growing focus on innovation in cell and gene therapies.

59

59

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmaceutical Commerce

JANUARY 20, 2025

Despite challenges surrounding communication overload, drug shortages, and cybersecurity risks, this term is revolutionizing medication management and patient care through the use artificial intelligence and predictive forecasting.

Hospitals 59

Hospitals Communication Patient Care 59

Pharmaceutical Technology

JANUARY 20, 2025

The Prolium deal highlights the growing trend of China-derived experimental therapies entering the US market.

59

59

Pharmaceutical Commerce

JANUARY 20, 2025

The latest news for pharma industry insiders.

59

59

Pharmaceutical Technology

JANUARY 20, 2025

If the results from the clinical development plans are positive, it may well reflect a paradigm shift for clinical care.

59

59

Pharma Times

JANUARY 20, 2025

Cell and Gene Therapy Catapult reveals significant growth in UK trials

58

58

Pharmaceutical Technology

JANUARY 20, 2025

Northwell Healths Feinstein Institutes for Medical Research has received a $2.9m grant from the NIH to explore the use of human ghrelin.

59

59

Pharmacy Times

JANUARY 20, 2025

Jennifer Clements, a clinical professor and the director of pharmacy education at the University of South Carolina, discusses the pharmacists role in diabetes care.

56

56

Pharmaceutical Technology

JANUARY 20, 2025

An FDA approval later this year for Arrowheads plozasiran in FCS would put it in direct competition with Ionis Tryngolza.

FDA 59

FDA 59

Outsourcing Pharma

JANUARY 20, 2025

We ran a Q&A with John Clarke, associate director in patient recruitment at Innovaderm on the changing landscape of patient centricity in terms of clinical trials and how the industry can navigate the evolving regulatory expectations around it.

53

53

Pharmaceutical Technology

JANUARY 20, 2025

Amgens LUMAKRAS and Vectibix combination has received approval from the US FDA for treating KRAS G12C-mutated mCRC.

FDA 59

FDA 59

Pharma Times

JANUARY 20, 2025

Collaboration aims to enhance accessibility of medicines information

52

52

PharmExec

JANUARY 20, 2025

Approval is based on data from the Phase III CodeBreaK 300 trial, which demonstrated that treatment with Lumakras and Vectibix significantly improved progression-free survival in patients with KRAS G12C-mutated metastatic colorectal cancer.

FDA 52

FDA 52

pharmaphorum

JANUARY 20, 2025

AI technology, such as GenAI and ChatGPT, is set to revolutionise experiences in 2025 across various industries, including life science. Learn more about the future of AI and its impact on the way we interact and innovate.

52

52

PharmExec

JANUARY 20, 2025

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52

52

pharmaphorum

JANUARY 20, 2025

Discover key insights on data analytics, wearable health devices, and AI-driven models in the life sciences industry in this informative report - Part 4. Stay informed on the latest trends and advancements shaping the industry.

52

52